Trade Mark Journal No.2026/026 26 June 2026
WO0000001921412 (40,42)
Office of origin: Switzerland
Date of International Registration:9 February 2026
Date of designation in the UK:
9 February 2026
International priority date claimed: 6 February 2026
(Switzerland)
- Class 40
- Consulting with respect to custom manufacturing of medication and biological products.
- Class 42
- Pharmaceutical drug development services; Pharmaceutical research and development; scientific laboratory services; scientific and technological services, namely, biological research and analysis; research and research services in the field of the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient expression of proteins; scientific research services for others in the field of biochemistry; design and development of computer hardware and software; development and research of new products for others; product development for others; product development consultation; product research and development; information technology consulting; computer software consulting; technological consulting concerning computer hardware and software systems to facilitate their selection, implementation and use; custom engineering services for others in the field of chemical and biological process engineering and facility engineering; technological services aimed at creating custom manufacturing capacity, technologies, market selection and portfolio mix for the life sciences and pharmaceutical industries; technological services aimed at creating scientific, technological and digital ecosystems for third parties in the life sciences and pharmaceutical industries.
Lonza Ltd.
Representative: von Arx Schmidiger Faber Rechtsanwälte, Neumarkt 15, CH-8405 Winterthur, SWITZERLAND